cNeuro is Combinostics’ cloud platform for quantitative assessment of brain images and for providing clinical decision support in neurological disorders.
Combinostics offers two modules in the cNeuro product family, cMRI and cDSI.
cMRI
Quantify volumes of 133 brain regions, vascular burden, medial temporal lobe atrophy (MTA) score, global cortical atrophy (GCA) scale and Fazekas scale.
Compare measures to reference data.
Review results interactively in a web viewer using a standard web browser and obtain a report.
cDSI
Compare neuropsychology, MRI, CSF and genetics measured from your patient to data of previously diagnosed cases.
Quantify the patient’s similarity relative to etiology (AD, FTLD, VaD and cognitive normal) and progression (stable and progressive MCI).
Visualize data in an intuitive way with our patented disease state fingerprint (DSI) technology.
Combinostics at HIMMS 2018
Combinostics will be attending the HIMMS conference in Las Vegas 5 – 8 March. We will showcase our cNeuro® cMRI application integrated into the Siemens Healthineers Digital Ecosystem in the Siemens Healthineers booth...
read moreCombinostics’ MRI quantification software cNeuro® cMRI available on the Siemens Healthineers Digital Ecosystem
Tampere March 5, 2018 – Combinostics and Siemens Healthineers today announced a partnership around distribution of Combinostics’ cNeuro® cMRI application through the Siemens Healthineers Digital Ecosystem. The recently FDA 510(k) cleared quantification software...
read moreFDA clears Combinostics’ MRI quantification software cNeuro cMRI
Tampere January 15, 2018 – The digital health company Combinostics received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its image quantification software cNeuro cMRI. The software enables clinicians to get objective measurements of atrophy in...
read more